Alvarion (ALVR) Posts Break-Even Q4 EPS, Tops by 2c; Guides Q409
More News related to ALVR
- Alvarion (ALVR) Selected by Adam Internet to Deploy WiMAX Network in Adelaide, Australia
- Alvarion(R) Chosen by Adam Internet to Deploy WiMAX(TM) Project in South Australia
- Oscar Gruss Downgrades Alvarion Ltd. (ALVR) to Hold; Cautious Outlook
- Stephens & Co Downgrades Alvarion Ltd. (ALVR) to Equalweight
- Alvarion (ALVR) Posts Break-Even Q4 EPS, Tops by 2c; Guides Q409
More News related to Earnings
- Nanosphere (NSPH) Receives 510(k) from U.S. FDA to Update RVNATSP to Include Flu Cultured Clinical Isolates with H1N1 Virus
- Transcept Pharma (TSPT) to Meet with U.S. FDA To Discuss NDA Response Letter for Intermezzo
- DARA BioSciences (DARA) Says Clinical Trial on KRN5500 Achieved Its Primary Endpoint
- Nymox Pharmaceutical (NYMX) Announces Positive Clinical Data on BPH Drug NX-1207
- ARCA Biopharma (ABIO) Annouces Gencaro OK'd by U.S. FDA for Fast Track Program
Alvarion (NASDAQ: ALVR) reports Q3 EPS of $0.00, 2 cents better than the analyst estimate of ($0.02). Revenue for the quarter was $58.40 million, which compares to the estimate of $57.87 million.
Sees Q409 revs of $55 - $63 million, and non-GAAP loss of ($0.04) to profit of $0.02. Consensus is $64.41 million and EPS of $0.01, respecitvely.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
